Earlier studies by Jonsson et al., on the involvement of APC/beta-catenin signaling in human breast cancer indicated that it is imperative to identify elements that selectively drive the oncogenic activity of beta-catenin in breast cancer [13]. The gene discussed is APC; the disease is breast carcinoma.